Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Advances in prostate cancer.

E J Small1

  • 1University of California, San Francisco, Mount Zion Cancer Center, 94115, USA.

Current Opinion in Oncology
|May 18, 1999
PubMed
Summary
This summary is machine-generated.

Advances in prostate cancer research include understanding genetic and environmental risk factors, improving screening methods, and optimizing therapies for various stages of the disease. Treatment for advanced and recurrent prostate cancer shows modest progress.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Niraparib plus abiraterone acetate with prednisone in patients with metastatic castration-resistant prostate cancer and homologous recombination repair gene alterations: second interim analysis of the randomized phase III MAGNITUDE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry.

Annals of oncology : official journal of the European Society for Medical Oncology·2021
Same author

Clinical outcomes in men of diverse ethnic backgrounds with metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026
Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026
Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026
Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026
Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026
Same journal

5-Fluorouracil at seventy: still attractive but barely understood. A cautionary tale for drug development.

Current opinion in oncology·2026
See all related articles

Area of Science:

  • Oncology
  • Urology

Background:

  • Prostate cancer development involves complex environmental and genetic interactions.
  • Screening improvements have decreased prostate cancer incidence.

Purpose of the Study:

  • To review significant observations in prostate cancer research from late 1997 to late 1998.
  • To highlight advances in understanding risk factors, screening, and therapy.

Main Methods:

  • Literature review of salient observations.
  • Analysis of advancements in screening and risk assessment.
  • Evaluation of therapeutic strategies for different prostate cancer stages.

Main Results:

  • Improved screening has reduced prostate cancer incidence.

Related Experiment Videos

  • Risk assessment and therapy have been enhanced for localized and recurrent disease.
  • Hormone therapy evaluated for advanced, node-positive, and de novo metastatic cancers.
  • Modest progress in treating androgen-independent prostate cancer.

    • Conclusions:

    • Significant advances in understanding prostate cancer risk factors, screening, and treatment optimization.
    • Ongoing research continues to refine therapeutic approaches for all stages of prostate cancer.